F8 and hemophilia: The present data are an extension of the earlier EUHASS report on inhibitor development in nonsevere hemophilia from 2008 until 2012 [6], reporting on prospectively collected data on inhibitor development according to FVIII/IX concentrates from 90 centers collected during 14.25 years (2008-2023).